/SCIB.ST
SCIB.ST Stock - SciBase Holding AB (publ)
Healthcare|Medical - DevicesSTO
$0.36+0.00%
+$0.00 (+0.00%) • Dec 23
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.63
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SCIB.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.36 – $0.36
TARGET (TP)$0.41
STOP LOSS$0.33
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.58
52W High$0.60
52W Low$0.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $29.70M | $23.25M | $17.89M | $11.73M | $9.52M |
| Gross Profit | $21.08M | $16.04M | $11.23M | $6.58M | $5.00M |
| Gross Margin | 71.0% | 69.0% | 62.8% | 56.1% | 52.5% |
| Operating Income | $-67,174,000 | $-53,939,000 | $-46,449,000 | $-42,410,000 | $-33,917,000 |
| Net Income | $-61,125,000 | $-55,585,000 | $-39,899,000 | $-41,690,000 | $-34,989,000 |
| Net Margin | -205.8% | -239.1% | -223.0% | -355.5% | -367.5% |
| EPS | $-0.34 | $-0.51 | $-0.57 | $-0.64 | $-1.09 |
Company Overview
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SCIB.STBeat Rate
18%
Last 11 quarters
Avg Surprise
-37.2%
EPS vs Estimate
Beats / Misses
2/8
1 met exactly
Latest EPS
$-0.05
Q4 2025
EPS Surprise History
Q1 24
-54.5%
$-0.17vs$-0.11
Q2 24
+25.0%
$-0.09vs$-0.12
Q3 24
-100.0%
$-0.08vs$-0.04
Q4 24
0.0%
$-0.08vs$-0.08
Q1 25
+20.0%
$-0.08vs$-0.10
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q4 2025 | Nov 7, 2025 | — | $-0.05 | — | — |
Q3 2025 | Aug 19, 2025 | — | $-0.08 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.09 | — | — |
Q1 2025 | Feb 25, 2025 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-0.08 | $-0.08 | 0.0% | = MET |
Q3 2024 | Aug 21, 2024 | $-0.04 | $-0.08 | -100.0% | ✗ MISS |
Q2 2024 | May 31, 2024 | $-0.12 | $-0.09 | +25.0% | ✓ BEAT |
Q1 2024 | Feb 21, 2024 | $-0.11 | $-0.17 | -54.5% | ✗ MISS |
Q4 2023 | Nov 10, 2023 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q3 2023 | Aug 18, 2023 | $-0.10 | $-0.16 | -60.0% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.10 | $-0.15 | -50.0% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $-0.10 | $-0.22 | -120.0% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.10 | $-0.13 | -30.0% | ✗ MISS |
Q3 2022 | Aug 18, 2022 | $-0.10 | $-0.13 | -30.0% | ✗ MISS |
Q2 2022 | May 12, 2022 | — | $-0.14 | — | — |
Q1 2022 | Feb 23, 2022 | — | $-0.17 | — | — |
Q4 2021 | Nov 11, 2021 | — | $-0.12 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.18 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SCIB.ST
What is SCIB.ST's current stock price?
SciBase Holding AB (publ) (SCIB.ST) is currently trading at $0.36 per share. The stock has moved +0.00% today.
What is the analyst price target for SCIB.ST?
No analyst price targets are currently available for this stock.
What sector is SciBase Holding AB (publ) in?
SciBase Holding AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is SCIB.ST's market cap?
SciBase Holding AB (publ) has a market capitalization of $0.15 billion, making it a small-cap company.
Does SCIB.ST pay dividends?
No, SciBase Holding AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARCOMA.ST
Arcoma AB
$7.50
Mkt Cap: $0.1B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
CMOTEC-B.ST
Scandinavian ChemoTech AB (publ)
$4.79
Mkt Cap: $0.1B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
ICO.ST
Iconovo AB (publ)
$1.14
Mkt Cap: $0.1B
IMMNOV.ST
Immunovia AB (publ)
$0.23
Mkt Cap: $0.1B
LXB.ST
Luxbright AB (publ)
$0.45
Mkt Cap: $0.1B
NICA.ST
Nanologica AB (publ)
$0.71
Mkt Cap: $0.1B
SPEC.ST
SpectraCure AB (publ)
$0.16
Mkt Cap: $0.1B
VIVE.ST
Vivesto AB
$0.14
Mkt Cap: $0.1B
Explore stocks similar to SCIB.ST for comparison